YTHDF2 and hepatocellular carcinoma: For instance, Zhang et al. documented that loss of YTHDF2 can impair the liver cancer stem cell (CSC) phenotype and inhibit cancer metastasis though decreasing the m6A methylation of OCT4 transcript, thereby showing YTHDF2 can act as a major oncogene driver of HCC (Zhang et al., 2020).